Skip to main content

Table 2 (abstract A28). See text for description

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Medication

Number of patients newly starting at or after enrollment

Methotrexate

898

Leflunomide

168

Sulfasalazine

95

Adalimumab

711

Etanercept

668

Infliximab

160

Abatacept

129

Tocilizumab

174

Anakinra

53

Canakinumab

81

  1. Number of patients who newly started selected medications at or after enrollment (N=6,707)
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096